Try our corporate solution for free!
(212) 419-8294
vianny.gutierrez-cruz@statista.com

Philippines: revenue growth of analgesics 2013-2025

Revenue growth of analgesics in the Philippines from 2013 to 2025

To view this statistic you need one of our Corporate Solutions, which includes the following benefits

  • Immediate access to statistics, forecasts, reports and market outlooks
  • Download as XLS, PPT, PNG and PDF
  • Detailed source and background information
Statista Corporate Solutions

Statista Corporate Solutions

Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Supplementary notes

The Analgesics segment comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

All figures are estimates. Details on the methodology can be found at https://cdn.statcdn.com/static/img/outlook/CMO-Methodik_en.pdf.

Use Statista now: unlimited access to all content

Statistics on "Pharmaceutical market in Italy"

Use Statista now: unlimited access to all content
Learn more about how Statista can support your business.